Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study

Brain

Volumn 122, Issue 11, 1999, Pages 2047-2056

  Reindl, Markus ^a   Linington, Chris ^b   Brehm, Uschi ^b   Egg, Robert ^a   Dilitz, Erika ^a   Deisenhammer, Florian ^a   Poewe, Werner ^a   Berger, Thomas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

Autoantibodies; Brain inflammation; Multiple sclerosis; Myelin basic protein; Myelin oligodendrocyte glycoprotein

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN G ANTIBODY; MYELIN BASIC PROTEIN; RECOMBINANT ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RHEUMATOID ARTHRITIS; SCHOOL CHILD;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVOUS SYSTEM DISEASES; NEURITIS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 0032723691     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.11.2047     Document Type: Article

References (51)

1. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM, et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995; 63: 17-27.
2. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153: 4349-56.
3. Baig S, Olsson T, Hojeberg B, Link H. Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis. Neurology 1991a; 41: 581-7.
4. Baig S, Olsson T, Yu-Ping J, Hojeberg B, Cruz M, Link H. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand J Immunol 1991b; 33: 73-79.
5. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J Neurochem 1989; 52: 296-304.
6. Eylar EH, Kniskern PJ, Jackson JJ. Myelin basic proteins. Methods Enzymol 1979; 32B: 323-41.
7. Prick E, Stickl H. Antibody-dependent lymphocyte cytotoxicity against basic protein of myelin in multiple sclerosis. J Neurol Sci 1980; 46:187-97.
8. Gardinier MV, Amiguet P, Linington C, Matthieu JM. Myelin/ oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 1992; 33: 177-87.
9. Gay D, Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study. Brain 1991; 114: 557-72.
10. Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995; 96: 2966-74.
11. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis [see comments]. Nat Med 1999; 5: 170-5. Comment in: Nat Med 1999; 5: 153-4.
12. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis [see comments]. Nat Med 1999; 5: 170-5. Comment in: Nat Med 1999; 5: 153-4.
13. Kerlero de Rosbo N, Honegger P, Lassmann H, Matthieu JM. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J Neurochem 1990; 55: 583-7.
14. Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993; 92: 2602-8.
15. Kroepfl JF, Viise LR, Charron AJ, Linington C, Gardinier MV. Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J Neurochem 1996; 67: 2219-22.
16. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
17. Lebar R, Lubetzki C, Vincent C, Lombrail P, Boutry JM. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin Exp Immunol 1986; 66: 423-34.
18. Linington C, Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 1987; 17: 61-9.
19. Linington C, Webb M, Woodhams PL. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 1984; 6; 387-96.
20. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ oligodendrocyte glycoprotein. Am J Pathol 1988; 130: 443-54.
21. Link H, Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397-401.
22. Litzenburger T, Fässler R, Bauer J, Lassmann H, Linington C, Wekerle H, et al. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 1998; 188: 169-80.
23. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. [Review]. Brain Pathol 1996; 6: 259-74.
24. McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain 1990; 113: 1269-89.
25. Mithen F, Bunge R, Agrawal H. Proteolipid protein antiserum does not affect CNS myelin in rat spinal cord culture. Brain Res 1980; 197: 477-83.
26. Mithen FA, Agrawal HC, Eylar EH, Fishman MA, Blank W, Bunge RP. Studies with antisera against peripheral nervous system myelin and myelin basic proteins. I. Effects of antiserum upon living cultures of nervous tissue. Brain Res 1982a; 250: 321-31.
27. Mithen FA, Agrawal HC, Fishman MA, Eylar EH, Bunge RP. Studies with antisera against peripheral nervous system myelin and myelin basic proteins. II. Immunohistochemical studies in cultures of rat dorsal root ganglion neurons and Schwann cells. Brain Res 1982b; 250: 333-43.
28. Moller JR, Johnson D, Brady RO, Tourtellotte WW, Quarles RH. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 1989; 22: 55-61.
29. Newcombe J, Gahan S, Cuzner ML. Serum antibodies against central nervous system proteins in human demyelinating disease. Clin Exp Immunol 1985; 59: 383-90.
30. Olsson T, Baig S, Höjeberg B, Link H. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann Neurol 1990; 27: 132-6.
31. Olsson T, Sun JB, Solders G, Xiao BG, Hojeberg B, Ekre HP, et al. Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J Neurol Sci 1993; 117: 130-9.
32. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-22.
33. Paterson PY, Day ED, Whitacre CC, Berenberg RA, Harter DH. Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis. J Neurol Sci 1981; 52: 37-51.
34. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
35. Pribyl TM, Campagnoni C, Kampf K, Handley VW, Campagnoni AT. The major myelin protein genes are expressed in the human thymus. J Neurosci Res 1996; 45: 812-9.
36. Prineas JW. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology, Vol. 47. Amsterdam: Elsevier Science; 1985. p. 213-57.
37. Prineas JW, Graham JS. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 1981; 10: 149-58.
38. Schluesener HJ, Sobel RA, Linington C, Weiner HL. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 1987; 139: 4016-21.
39. Scolding NJ, Morgan BP, Houston WA, Linington C, Campbell AK, Compston DA. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 1989; 339: 620-2.
40. Seil FJ, Agrawal HC. Myelin-proteolipid protein does not induce demyelinating or myelination-inhibiting antibodies. Brain Res 1980; 194: 273-7.
41. Seil FJ, Quarles RH, Johnson D, Brady RO. Immunization with purified myelin-associated glycoprotein does not evoke myelination-inhibiting or demyelinating antibodies. Brain Res 1981; 209: 470-5.
42. Sellebjerg F, Madsen HO, Frederiksen JL, Ryder LP, Svejgaard A. Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system. Ann Neurol 1995; 38: 943-50.
43. Solders G, Correale J, Zhi W, Hojeberg B, Link H, Olsson T. Increased systemic B-and T-lymphocyte responses in hereditary motor and sensory neuropathy (HMSN I). J Neurol Sci 1992; 113: 62-9.
44. Storch MK, Piddlesden S, Haltia M, livanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibodyand complement-mediated demyelination. Ann Neurol 1998a; 43: 465-71.
45. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998b; 8: 681-94.
46. Sun J, Link H, Olsson T, Xiao BG, Andersson G, Ekre HP, et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 1991; 146: 1490-5.
47. Wallström E, Khademi M, Andersson M, Weissert R, Linington C, Olsson T. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis. Eur J Immunol 1998; 28: 3329-35.
48. Walsh MJ, Murray JM. Dual implication of 2′,3′-cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J Clin Invest 1998; 101: 1923-31.
49. Wang WZ, Olsson T, Kostulas V, Hojeberg B, Ekre HP, Link H. Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol 1992; 88: 157-62.
50. Warren KG, Catz I. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J Neurol Sci 1994; 121: 66-73.
51. Xiao BG, Linington C, Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 1991; 31: 91-6.